Eucrisa regulatory update

FDA approved an NDA from Pfizer for Eucrisa crisaborole 2% ointment to treat mild to moderate atopic dermatitis in patients ages ≥2. Pfizer said the company plans to launch Eucrisa by the end of Janua...